Consorci Sanitari de Terrassa   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Barcelona Spain (1989)

Organization Overview

First Clinical Trial
2005
NCT00917592
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Consorci Sanitari de Terrasa | Consorci Sanitari de Terrassa | Consorci Sanitari de Terrassa (CST) | Consorci Sanitari de Terrassa. Hospital de Terrassa | Hospital de Terrassa | Jose Antonio Bernia Gil | Leonor Cuadra Llopart

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colorectal Neoplasms (Phase 2)

Diverticulitis (Phase 4)

Fractures, Bone (Phase 4)

Hip Fractures (Phase 4)

Lung Neoplasms (Phase 2)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 18